KYKylie Yang

Kylie Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kylie Yang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Amino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer

    by Precious I. A. Popoola, Thomas L. Allam, Rebecca J. Lilley, Chandni Manwani, Olivia B. Keers, Junyang Tan, Kylie Yang, Yifan Long, Ewan R. Clark, Lisa J. White, et al.

    Novel amphiphiles target cell membranes, demonstrating biological efficacy against resistant S. aureus and ovarian cancer, with strong mechanistic and DMPK evidence for future therapeutic development.


  • Open Access

    An increased throughput workflow to identify ion transport and membrane lysis agents for antimicrobial discovery

    by Kylie Yang, Caleb Marsh, Lisa J. White, Fergus W. Molyneux, Thomas L. Allam, Precious I. A. Popoola, Olivia B. Keers, Matthew Rice, Kira L. F. Hilton, Hiral A. Kotak, et al.

    Small molecule ion transporters have shown promise as potential therapeutics for microbial infections, cancer and channelopathies. However, there are still gaps in our understanding of how ion transport function in model vesicle membranes translates to cell membranes of interest. The lipid composition of the membranes of bacterial and cancer cells differs markedly from normal human cells, yet the influence of the lipid composition on membrane function is rarely investigated – in part because of the low throughput and high cost of ion transport experiments. Here, we report an increased throughput Workflow to identify biologically relevant, pH-driven ion transport and membrane lysis pathways in vesicle membranes. We developed a set of four assays designed to report on different transport and lysis processes. We validated our assays against a panel of known transporters and produced a stepwise Workflow for the evaluation of libraries of compounds. We applied our Workflow to screen a library (Library 1) of 31 supramolecular, self-associating amphiphiles (SSAs) for transport and lysis activity in a range of vesicles with different lipid compositions, designed to mimic different types of cells, and consequently identified seven promising transporters. Antimicrobial experiments found that six of these promising transporters showed good antimicrobial activity against clinically relevant Staphylococcus aureus strains, highlighting the promise of our Workflow in identifying potential antimicrobial agents. We then applied our Workflow to investigate the ion transport and lysis properties of a second library (Library 2) of SSAs with established antimicrobial and anticancer properties, aiming to provide insight into the biological modes of action.


  • Open Access

    Amino acid appended supramolecular self-associating amphiphiles demonstrate dual activity against both MRSA and ovarian cancer

    by Precious Popoola, Thomas Allam, Rebecca Lilley, Chandni Manwani, Olivia Keers, Junyang Tan, Kylie Yang, Yifan Long, Lisa White, Kira Hilton, et al.

    Differences in the lipid composition of prokaryotic and eukaryotic cell membranes are well understood and can be exploited to produce novel antimicrobials. However, what is less well recognised is that alteration in the phospholipid composition of the cell membrane is also one of the first phenotypic changes when a cell becomes cancerous. In addition, changes in phospholipid cell membrane composition are a known cause of drug resistance in both microbial disease and cancer. Here we present a series of chiral, amino acid appended supramolecular self-associating amphiphiles that suggest membrane active technologies can be used to simultaneously produce novel drugs in the fight against two of the greatest global health threats facing us today, antimicrobial resistant infections and cancer diseases. We demonstrate the antimicrobial and anticancer efficacy of this membrane active amphiphile technology against susceptible and resistant Staphylococcus aureus and ovarian cancer cells. We hypothesise a mode of action, building on a previous body of evidence, through a combination of vesicle, NMR spectroscopy and patch clamp experiments. We also provide evidence that supports the potential for this class of compound to be developed as pharmaceutical agents against these diseases through in vitro drug metabolism and pharmacokinetics experiments alongside in vivo Galleria mellonella toxicity experiments.


  • Open Access

    High‐Throughput and Automated Anion Transport Assays

    by Kylie Yang, Lana C. Lee, Hiral A. Kotak, Evelyn R. Morton, Soo Mei Chee, Duy P. M. Nguyen, Alvaro Keskküla, Cally J. E. Haynes

    Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time‐consuming and resource‐intensive, hindering the screening of large compound libraries. In this work we have developed an automated high‐throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl−/NO3− antiport method, has been optimised for multi‐well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.


  • Open Access

    High-throughput and Automated Anion Transport Assays

    by Kylie Yang, Lana Lee, Hiral Kotak, Evelyn Morton, Soo Mei Chee, Duy Nguyen, Alvaro Keskküla, Cally Haynes

    Ion transport across biological lipid membranes is crucial for both health and disease, prompting investigation into synthetic ion transporters as potential therapeutics. However, state of the art methods for assessing transporter activity are often time-consuming and resource-intensive, hindering the screening of large compound libraries. In this work we have developed an automated high-throughput assay capable of determining 24 EC50 values in a single day. This assay, adapted from the established lucigenin Cl-/NO3- antiport method, has been optimised for multi-well plates with fully automated liquid handling. Notably, our protocol allows for the use of DMSO as a delivery solvent for target molecules, enhancing its versatility. Validation with six standard ion transporters demonstrated a strong correlation between the EC50 values obtained through our assay and previously reported values, confirming its efficacy and potential for broader applications in the field of ion transport.

  • Open Access

    A water-soluble membrane transporter for biologically relevant cations

    by Kylie Yang, Jessica E. Boles, Lisa J. White, Kira L. F. Hilton, Hin Yuk Lai, Yifan Long, Jennifer R. Hiscock, Cally J. E. Haynes

    Synthetic ionophores are promising therapeutic targets, yet poor water solubility limits their potential for translation into the clinic. Here we report a water soluble, supramolecular self-associating amphiphile (SSA) with cation transport function.


  • Strategies for organelle targeting of fluorescent probes

    by Jiarun Lin, Kylie Yang, Elizabeth J. New

    Here we provide a comprehensive review of methods for targeting fluorescent cargo to sub-cellular organelles.